Jakura, branded as tofacitinib, in its 5mg dosage, represents a significant advance in the treatment of rheumatoid arthritis (RA). This oral medication, a selective Janus kinase (JAK) inhibitor, works by suppressing the signaling pathways that contribute to inflammation and joint damage character